2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 3 Not applicable, 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage IV: new trials by email Literature Review of Stage IV trials Research Report on Stage IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy), Surgery, Radiotherapy - Non-small Cell Lung Cancer (NSCLC), Stage IV | Not applicable | Recruiting | Swiss Cancer Institute | 128 | 2023-12-21 | 2026-04-02 |
| Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment Rigosertib, Nivolumab - Non-small Cell Lung Cancer, Adenocarcinoma | Phase 1 / Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 25 | 2020-06-29 | 2024-05-09 |
| Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC Durvalumab, Carboplatin, Paclitaxel - Non-small Cell Lung Cancer, Stage IV | Phase 2 | Active not recruiting | ETOP IBCSG Partners Foundation | 96 | 2019-11-19 | 2026-10-05 |
| Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer Aggressive Thoracic Radiotherapy - Carcinoma, Non-Small-Cell Lung, Stage IV | Not applicable | Unknown | yu gengsheng | 60 | 2018-12-10 | 2018-12-26 |
| Improving Goals of Care Discussion in Advanced Cancer Patients GoC intervention - Primary Stage IV Hepatobiliary, Esophageal | Not applicable | Completed | Icahn School of Medicine at Mount Sinai | 265 | 2016-03-15 | 2019-10-01 |
| Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC oxaliplatin, Cisplatin - Stomach Neoplasm, Stage IV | Phase 2 | Unknown | Gachon University Gil Medical Center | 90 | 2007-07-01 | 2007-08-01 |
Carcinoma, Non-Small-Cell Lung (4) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Neoplasms (6) · Neoplasms by Site (6) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Respiratory Tract Neoplasms (5) · Thoracic Neoplasms (5) · Bronchial Neoplasms (4) · Carcinoma, Bronchogenic (4) · Lung Neoplasms (4) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2)
Carboplatin (1) · Cisplatin (1) · Nivolumab (1) · ON 01910 (1) · Oxaliplatin (1) · Paclitaxel (1) · Radiosurgery (1) · Radiotherapy (1) · Surgical Procedures, Operative (1) · durvalumab (1) · tremelimumab (1)
Icahn School of Medicine at Mount Sinai (2) · ETOP IBCSG Partners Foundation (1) · Gachon University Gil Medical Center (1) · Swiss Cancer Institute (1) · yu gengsheng (1)
Switzerland (2) · United States (2) · China (1) · Italy (1) · Netherlands (1) · South Korea (1) · Spain (1)
Isabelle Schmitt-Opitz, MD (1) · Isabelle Schmitt-Opitz, Prof (1) · Matthias Guckenberger, MD-PhD (1) · Nina Bickell, MD, MPH (1) · Rajwanth Veluswamy, MD, MSCR (1) · Se Hoon Park, MD (1) · Yu Gengsheng, master (1)
2018 (1)